Fresh Tracks Therapeutics (FRTX) Q4 2022 Earnings

30MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-3.6
-2.4
-1.21
-0.01

Details

Expected EPS
-1.43
Actual EPS
-1.5
Surprise EPS
-0.07
Surprise Percent
+4.9%

Description

Fresh Tracks Therapeutics (FRTX) has reported earnings of -1.5 per share for Q4 2022.

0 Comments

Share your thoughts